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Abstract: Objective: To identify new technological advances in biotechnology, nanotechnology and robotics and their 
application in diagnosis and therapeutics for visual health.  
Methodology: The systematic review was made in Journal of Engineering, Journal of Biomedical Nanotechnology, NIH 
Public Access, Investigative Ophthalmology & Visual Science, Intechweb open access journal and books, among others 
for a total review of 43 articles and 6 books. The databases used were: NLM Catalogue, (NCBI), Scirus, CiteSeer and 
open access (Intechopen, Hindawi) with the advances in nanotechnology, artificial vision and robotics applied to visual 
health.  
Results: Retina implants, ocular memristors, ocular electrodes and chips, digital cameras and smart phone applications 
for low vision patients are some of the new alternatives in technology for the diagnosis based on biotechnology and 
nanotechnology and on the several years of job of interdisciplinary and multidisciplinary researchers of different fields to 
make innovation useful for visual impairment, ocular microbiology and molecular immunodiagnostics. The FDA recently 
approved the retina implants and this opened a new field to allow converting light signals into electrical signals. On the 
other hand, in the field of pharmacology, ocular nano-carrier molecules for sustained release of drugs and other devices 
to vitrectomies are some of the significant health advance studies for the future in visual health. Additionally, in the field 
of contact lenses and artificial corneas: biopolymers for biosensors have been developed for early detection of 
keratoconus and systemic diseases.  
Conclusions: Nanotechnology, biotechnology, robotics and bio-molecular biology are emerging and convergent sciences 
that when applied to visual sciences will be helpful for the patients, and are an increase in papers on innovation of this 
field, involving a multidisciplinary team requiring new divulgation in the role and performance of the visual health 
professionals of the future. To know and divulgate these new technologies is important for continued joint efforts around 
global education, and to create a database with new keywords, in order to know who and where these innovations are 
improving around the world, to planning researcher mobility and to include these new valuable technologies in the 
curriculum of visual health and get the patient safe. 
Keywords: Nanotechnology, Memristors, Nanopolymer, Nancocarrier, artificial vision, biosensors, Retinal implants, 
Ophthalmology, Visual Sciences, theragnostic, contact lenses, ocular biopolymers. 
INTRODUCTION 
Emerging and converging technologies are terms 
used interchangeably to indicate the emergence and 
convergence of new technologies [1] with 
demonstrated potential as disruptive technologies. 
Among them are: nanotechnology, biotechnology, 
information technology and communication, cognitive 
science, robotics, and artificial intelligence that have 
been launched as innovative products that promise to 
improve the quality of life and vision of patients with 
ocular compromised or low vision impairment. Some 
acronyms for these are: 
NBIC: Nanotechnology, Biotechnology, Information 
technology and Cognitive science.  
GNR: Genetics, Nanotechnology and Robotics. 
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Figure 1: Map of “Convergent technologies” operated 
systems for ophthalmic applications: Now to the future. 
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In the map of emergent technologies the 
nanotechnology, biotechnology, information technology 
and cognitive sciences (NBIC) leave open many 
sciences to come and help with these innovations and 
it requires visionary observers and researchers, in a 
transdisciplinary researching process, to create new 
alternatives in the prevention of blindness or diagnosis 
of ocular pathologies on time. In Ophthalmic surgery: 
wavefront, lasers femtosecond, and surgical 
instruments form part of these technologies, and more 
recently with the introduction of retina implants (Argus 
II), artificial corneas, and new molecular rapid tests for 
detection of ocular infections, diagnosis and 
therapeutics required team groups working as “global 
interactive researchers communities” of several 
research groups in a complex equipment and multiple 
labs trying to resolve blindness, improve surgical 
ophthalmic techniques, drug innovations and try to 
prevent harmful microorganisms in ocular infections, 
and improve new surgical techniques, among others. 
Some indicators of these worldwide ophthalmic 
innovations are: applications to improve low vision, the 
creation of retinal implants, the application of 
biopolymers for creating artificial corneas, memristors: 
electronic devices for low vision and prosthesis for the 
retina among others. The implementation of 
mathematical models and the simulation of virtual 
reality systems, electronic devices known as MEMs 
(micro-electromechanical systems) based on models of 
augmented reality, are now possible. For some time, 
what was once considered as science fiction for bionic 
eyes, electronic implants are becoming more a reality 
and the technology must respond to specific visual 
disorders and impairments to restore vision. The 
challenge for institutions and researchers is to join 
groups around the world as a “collaborative 
investigation of groups that research global visual 
health” and work together within different disciplines. 
For ten or more years joint efforts and resources, 
revised university curricula, inclusion of masters and 
doctorates including those sciences that only a few 
years ago were reserved for biomedical or electronic 
engineers, but that today require ongoing 
communication between eye care professionals and 
other sciences such as electronic engineering, robotics 
and mechatronics to ensure that the devices meet the 
visual needs of the population. This article is a review 
of the products for innovative eye care coming to the 
market based on nanotechnology, robotics for visual 
health between now and the near future. The first 
studies of Nanotechnology were included by the 
Feynman physics at the annual meeting of the 
American Physical Society at the California Institute of 
Technology [2]. 
For many years, science has provided invaluable 
tools in eye care by creating diagnostic equipment 
(physics: interferometry, ultrasound, laser), and in 
chemistry and biotechnology advances (ophthalmic 
products for treatment and diagnosis, contact lens 
biopolymers, rapid diagnostic test based PCR). 
Recently, new advances in gene therapy, 
nanotechnology, retina implants and robotic surgery 
are entering ophthalmology surgery to restore low 
vision and to design rapid tests for molecular diagnosis 
of ocular diseases by means of molecular biology. 
METHODOLOGY 
A total of 89 articles were reviewed from 42 journals 
of Ophthalmology, Nanomedicine, Biotechnology, 
Ocular Therapy and Robotics. The databases used 
were: NLM Catalogue, (NCBI), Scirus, CiteSeer and 
open access (Intechopen, Hindawi) and the keywords 
were then selected: Nanotechnology, Memristors, 
Nanopolymers, Nanocarrier, biosensors, Retinal 
implants, ophthalmology, Chitosan, contact lenses, 
ocular biopolymers, theragnostic. Citations extracted 
from Software End Note V5. To control bias, the 
inclusion criteria for articles on Journals and Books 
were selected from Ophthalmics application including 
convergent technologies: 46 completed the inclusion 
requirements and six books were reviewed. 
RESULTS 
After the systematic review, the most relevant 
ophthalmic applications of the convergent technologies 
found were: 
• Retina implants 
• Drug delivery, nanocarriers, dendrimers for 
ophthalmic therapy 
• Information technology and cognitive science. 
• Intelligent contact lenses 
• Theragnostic and rapid test diagnostics for 
detection of microorganisms and dry eye 
• Stem cells 
• Haptic and robotics for ophthalmology surgery 
and therapeutics 
Some of the ophthalmic applications on those fields 
are listed on Table 1. 
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Table 1: Review of Ophthalmic Applications of Emerging and Converging Technologies 
TECHNOLOGIES PRINCIPLE OPHTHALMIC APPLICATION 
Nanotechnology 
Nanoshells Is a type of nanoparticles consisting of a dielectric core 
which is covered by a thin metallic shell. Involve a particle 
called plasmon which is a collective excitation or quantum 
plasma oscillation where the electrons simultaneously 
oscillate with respect to all the ions. 
Drug delivery, ocular dispositive against 
microbe colonization 
Contact lens cases, 
Intraocular lenses 
Nanotubes Tubes at nanoscale (10-9mm) created by laser ablation 
creating “nanoarrays” to electrical transport mechanical 
properties. 
Carbone nanotubes for ocular prosthesis 
Drug delivery 
Nanorecovers 
Ophthalmic and contact lenses 
Memrtistors Nanotransistors, nanotechnologic devices that allow 
ultrafast flash and "smart" memories. Memristors are 
electrical circuit, joining the resistor, the capacitor, and the 
inductor, that exhibit unique properties at the nanoscale. 
MEMS: micro-electro-mechanical systems. 
Artificial retinas. Biomimetic model of outer 
plexiform layer. Neuro-ophthalmolgy. 
Replace tissues. Stimulate retina´s cells. 
Ocular diseases and therapeutic 
(theragnosis) 
Nanocarriers 
Nanomicelles 
Nanocarriers as a colloidal particulate systems with size 
ranging between 10 - 1000 nm such as of poly (D,L-lactic 
acid, PLA NPs), 
Nanomicelles as a nanomolecular aggregates with 
hydrophilic polar part and a nonpolar hydrophobic 50 
nanometers in diameter, which allowed staying longer in 
the body and transporting protein and going through 
physiological channels that do not allow premature 
degradation in the body and provide longer lasting effects 
Diagnosis, treatment and monitoring of 
various diseases. Enhance absorption of 
the ophthalmic drugs into a selected tissue, 
control the pharmacokinetic and drug 
tissue distribution profile and improve the 
intracellular penetration 
Biotechnology / Molecular Biology 
Biopolymers Biomaterial ensambled with steam cells and organical 
compounds  
Bionsensors to detect ocular diseases 
Artificial Corneas 
Artificial Vítreo 
Intelligent contact lenses 
Ophthalmic drugs 
Biosensors Consists of two components: a bioreceptor and a 
transducer. Is a biomolecule that recognizes the target 
whereas the transducer converts the recognition event into 
a measurable signal. The uniqueness of a biosensor is that 
the two components are integrated into one single sensor 
Detect ocular diseases, glaucoma, 
Intelligent contact lenses, detect 
photoreceptor degeneration, Rapid test for 
ophthalmic diagnosis 
Stem cells Biological cells found in all multicellular organisms, that 
can divide by mitosis and differentiate into diverse 
specialized cell types and can self-renew to produce more 
stem cells 
Ocular tissue regeneration 
Corneal transplants 
Retina cell therapy 
Control Blindness 
Information technology/Robotics 
Robotic  Is the branch of technology in relation with the design, 
application, construction and application of robots 
Surgical instruments 
Ophthalmic haptics 
Informatics Technologies (IT) Is the application of computers and telecommunications 
equipment to store, retrieve, transmit and manipulate data 
Tele-ophthalmology, Smartphone 
applications for low vision, integration to 
retina camera and diagnosis exams 
3 D model and simulation 
software 
Are graphics that use a three-dimensional representation of 
geometric data is stored in the computer for the purposes of 
performing calculations and rendering 2D images.  
Design of surgical trainers for acquisition of 
ophthalmic skills, prototypes for future 
ophthalmic innovations 
Cognitive sciences 
Cognitive sciences Interdisciplinary study of mind and intelligence, embracing 
philosophy, psychology, artificial intelligence, neuroscience, 
linguistics, and anthropology 
Visual cognitive neurosciences 
Artificial Intelligent  
Vision rehabilitation 
Low vision 
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Retina Implants 
In France, at lab LIS-CEA, Saclay, retinal implants 
have been studied based on diamond nanomaterials 
and nanoparticles. The capabilities of many digital 
electronic devices and computer employees who 
respond to Moore's Law (processing speed, memory 
capacity, number of pixels) used in digital technology 
evolves towards the development of memristors 
(memory transistors, transistors that once inspired the 
creation of the cardiac pacemaker), which are 
nanotechnological devices that create intelligent flash. 
Since 1971 the concept introduced by Leon O. Chua 
has been developed as a model of neural networks, 
which are a biomimetic model of the retina that could 
even deliver 3D signals [3]. 
The introduction of microchips with silicon, known 
as a ”wafer”, was an open minded project to develop a 
biological and electronic device, as functional circuits 
that interact with living cells, it is the promise for now 
and the future [4]. Researchers are building tiny three-
dimensional models of human organs that can be used 
for treatment, as well as replace costly and time-
consuming animal studies that currently hamper drug 
development. Also, the Micro-electromechanical 
systems (MEMs) allow developed tests by providing 
increasing complexity for cell culture without having to 
use a whole tissue [5]. These biomimetic microsystems 
can replicate the functions of the organic structure and 
replace the functions of a complete tissue, and this is 
so useful to replicate mechanical and biochemical 
functions of blood and tissue as a nano-lab on a chip. 
Recently, these microsystems can be used to verify 
pharmacological effects of drugs, by replacing the 
animal model and just use tissue tests [6]. 
For more than ten years, physicians have been 
working with an interdisciplinary research group on the 
project: Second Sight's Argus II. A retinal prosthesis 
developed by Second Sight, Inc., with funding from the 
National Eye Institute, was recently recognized by the 
United States Patent and Trademark Office (USPTO), 
by the FDA in 2012 in the U.S.A. and by the European 
Union. It consists of a camera that captures images 
through implanted electrodes that stimulate cells in the 
retina, producing light in the field of vision of the 
patient, This camera mounted on a pair of eyeglasses 
wirelessly (it now has 60 electrodes with the hope for 
1500), with a microelectrode array consisting of 200 μm 
diameter disc electrodes, an inductive coil link used to 
transmit power and data to the internal portion of the 
implant, an external belt worn with a video processing 
unit (VPU) and a miniature camera mounted on a pair 
of glasses which act as photodiodes sensitive to light, 
so that the chip is more sensitive, the video camera 
captures a portion of the visual field and relays the 
information to the VPU. The VPU digitizes the signal in 
real-time, applies a series of image processing filters, 
down-samples the image to a 6?10 pixelated grid, and 
creates a series of stimulus pulses based on pixel 
brightness values and look-up tables customized for 
each subject. The system is implanted in the retina and 
permits recognition of simple objects, track movement 
 
Figure 2: Schematic model of a memristor. 
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and objects while walking. In the U.S.A. 28 subjects 
with light perception vision that received the implant 
were monitored and evaluated. Multiple blind subjects 
fitted with the Argus II system consistently identified 
letters and words using the device, indicating 
reproducible spatial resolution [7]. 
Drug Delivery, Nanocarrier, Dendrimers for 
Ophthalmic Therapy 
Other developments at the level of visual health 
pharmacology is the finding of nanocarriers for drug 
delivery. Among the most recent findings include: 
Nanomicells 
Nanomolecular aggregates with hydrophilic polar 
part and a nonpolar hydrophobic 50 nanometers in 
diameter, which allowed staying longer in the body and 
transporting protein and going through physiological 
channels that do not allow premature degradation in 
the body and provide longer lasting effects. As an 
example, the chitosan nanomicells are used for ocular 
drug delivery [8]. 
Nanocarriers 
For topical preparation nanocarriers of poly (D,L-
lactic acid, PLA NPs), those nanoparticles with 5-
fluorouracil permits that for the small dimension and 
shape of nanoparticles, can penetrate the vitreous 
humor in the same way, there is not significant 
interaction between mucin and PLA NPs. Another 
carbohydrate acting as a nanocarrier is the introduction 
of non-polymeric permeabilizers in the permeation of 
acyclovir across excised rabbit cornea. The use of this 
with acyclovir contributes to solve problems with its 
solubility in tear fluid at the physiological pH of 7.4. As 
soon as the instillation is made, the physiological pH of 
the tear fluid is restored [9]. 
Dendrimers 
Macromolecules of high stability to transport drugs 
which have recently been proposed as vectors for gene 
delivery, contrast agents for molecular imaging and 
nanocarriers. 
Nanoparticles 
As polymer spheres are nano-capsules or devices 
that allow the drugs to be surrounded by a single layer 
or be nano-matrices to prevent fungal growth or 
microorganisms such as nano-coatings [10], [11]. Most 
are made from metal ions like silver and are used to 
reduce biofilm and adherence of microorganism to 
contact lens cases. 
Carbon Nanotubes 
Cylindrical structures composed of layers of 
graphite or carbon material rolled and function as 
bioactive peptides, proteins, nucleic acids or drugs that 
release their load in the target cells. Being low toxicity 
molecules enables controlled drug release [12]. 
Polymer Conjugates 
Systems for delivering drugs that fall into two major 
subgroups, polymer-protein conjugates or polymer-
drug, which are formed by polyglutamic acids, 
polysaccharides, polyethylene and allow to only act in 
the target cell [13,14]. 
Theragnostic 
The term theragnostic test is herein defined as a 
molecular test that is integrated in the drug 
development process so as to guide patient selection 
and drug treatment protocols. It is based on subtle 
genotypic or phenotypic variations, including nucleotide 
or amino acid substitutions at the level of DNA, RNA or 
protein. In ophthalmology it has been useful for 
oxidative stress treatment, measurement of intraocular 
pressure and treatment of new vessels, prevent 
scarring after glaucoma surgery and retinal 
degenerative diseases [15]. 
Some progress of these new technologies in ocular 
pharmacology include cyclosporine [16], the CF-101, 
A-3 oral receptor adenosine agonists, corticoids with 
iontophoresis EGP-437, low doses of bromfenac 
among others, an LFA-1 antagonist and anti-
inflammatory secretagogue for corneal hydration, and 
the introduction of chitosan, a linear polysaccharide 
composed for ?-(1-4)-linked D-glucosamine and N-
acetyl-D-glucosamine and made by treating shrimp and 
other crustaceans shells with alkali sodium hydroxide 
[17-21]. 
Information Technology and Cognitive Science 
The advances in digital images, interferometry and 
ultrasounds, permits now a better differential diagnosis 
and let in vivo to observe ocular malfunction. One of 
those examples are optical coherence tomography 
(OCT) and ultrasound biomicroscopy (UBM) which 
have enhanced the surgeon’s ability to localize 
pathology both pre- and intra-operatively. 
Simultaneously, the approved femtosecond laser 
devices have been optimized for wound construction, 
capsulorhexis creation, and nucleus breakdown during 
cataract surgery. New utilities and the integration of a 
robotic system with OCT have been proposed for 
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vitreoretinal surgery, and the addition of laser 
technology would facilitate automation of surgery to 
treat cataracts. 
Intelligent Contact Lenses 
To prevent biofilm adherence, silver nano-film has 
been developed of one cleaning solution preserved 
with alexidine. The cases and containers will be 
protected with silver nanofilm in order to prevent the 
adherence and colonization of microorganisms. Special 
studies will be developed with fungus sp. and not just 
bacteria; because the fungus keratitis is more 
aggressive at the corneal stromal in contact lenses 
users. Researchers in this fiel, also recognize that the 
original Fusarium keratitis epidemic of past years 
remain unclear [22]. Also, mixed infections may occur 
in contact case lenses between bacteria and fungus 
and infect post-keratoplasties transplants [23]. 
Other applications have been in contact lenses, with 
the implementation of diagnostic sensors to measure 
the corneal curvature changes caused by changes in 
intraocular pressure via two antennas with wireless 
communication and integrated electronic circuits 
compatible with biopolymers, the great challenge is the 
integration of special circuits that are not toxic to the 
ocular surface. Nowadays, LEDs aluminum gallium 
arsenide are toxic materials which cannot therefore be 
used for this purpose, additionally, these polymers 
must be fully transparent [24]. 
Recently, one of the most recognized 
ophthalmological research groups joined together in 
the project Prosthetic Replacement of the Ocular 
Surface Ecosystem (PROSE). Treatment in the Boston 
Foundation for sight prosthetic devices, PROSE 
consists of a transparent domo made of RGP contact 
lens material that permits oxygen to reach the cornea 
and fit under the eyelids and rest on the sclera vaulting 
the damaged cornea and creating a new smooth 
optical surface that protects the eye from the 
environment and blink trauma. As a liquid reservoir 
inside the domo, they are filled with sterile saline that 
remains in the devices. PROSE creates a new 
transparent, smooth optical surface over the irregular, 
damaged or diseased cornea, expanding the artificial 
tear reservoir that provides constant lubrication while 
maintaining it necessary for the treatment of several 
ocular dysfunction as dry eye, limbal stem cell 
deficiency (aniridia, Steven Johnson, thermal injury, 
conjunctivitis) [22]. 
In Switzerland, the Triggerfish® sensor is a soft 
single-use contact lens with embedded strain gauges 
to measure fluctuations in IOP at the junction between 
the cornea and sclera. Also embedded are the 
telemetric chip and micro-loop antenna for wireless 
reception of power and data output. The signal sent 
from the micro-antenna is directly correlated to 
changing IOP (Sensimed 2010).  
Effective monitoring involves wearing the 
Triggerfish® system for up to 24 hours during which 
the patient carries out normal activities, including sleep. 
The system comprises the contact lens sensor, a 
flexible adhesive antenna which fits around the eye, 
and a recorder which is connected to the antenna via a 
thin, flexible data cable. At the conclusion of 24 hours, 
data is uploaded wirelessly via Bluetooth connectivity 
to a practitioner’s computer for assessment [25]. 
Everyday more and more scientific literature reports 
that the future of “smart contact lenses” show a lot of 
varieties for detection of diabetes and communication 
options in the most attractive advances [26]. 
Rapid Diagnosis Test for Detection of 
Microorganisms and Dry Eye (Theragnosis) 
For rapid diagnosis of adenoviral conjunctivitis with 
direct sampling microfiltration, similar to a pregnancy 
test, using incorporated colorimetric: blue control line is 
negative, and a red test line is positive for adenoviral 
particles (AdenoPlus, Rapid Pathogen Screening Inc.), 
which detects the most common cause of viral and 
validation and gold standard tests are on research with 
128 patients. The procedure consists of the collected 
results with the test adenoviral and requires just 10 
minutes to obtain results. It will be so helpful for 
differential diagnosis “in situ” in primary ocular care, 
because epidemiological of ECK, (epidemic 
keratoconjunctivitis) is a frequent misdiagnosis with 
allergy or bacterial conjunctivitis and will be a good 
alternative for adequate treatment [27]. 
In other important efforts to detect dry eye “in situ”, 
another rapid test is being developed by the same 
researchers (InflammaDry, Rapid Pathogen Screening 
Inc.) to detect matrix metalloproteinase 9 (MMP9), a 
biomarker of inflammation expressed in dry eyes. He 
said it is important to detect the condition for patient 
comfort, for preventing ocular morbidity, and for other 
management decisions. 
To test InflammaDry, researchers enrolled 143 
patients aged 18 years or older with clinical signs and 
symptoms of dry eyes and 63 healthy control 
individuals. All were assessed and determined to have 
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dry eyes or to be healthy using the Ocular Surface 
Disease Index. Also it detects MMP9 in 10 minutes 
greater than40 ng/mL. Previous studies have shown 
that the severity of dry eye correlates well with the level 
of MMP9 in the tears. [28]. 
Stem Cells 
The theragnosis based on subtle genotypic or 
phenotypic variations, including nucleotide or amino 
acid substitutions at the level of DNA, RNA or protein is 
oxidative stress treatment, measurement of intraocular 
pressure and treatment of new vessels, prevent 
scarring after glaucoma surgery and retinal 
degenerative diseases. And on a molecular basis, stem 
cells also contribute to therapy in glaucoma and other 
applications. The human adipose tissue is a source of 
multipotent stem cells. Preparations of lipo-aspirates 
cells can differentiate into osteogenic, adipogenic, 
muogenic, neurogenic as mesenchymal stem cells. 
The orbital adipose stem cell population are starting to 
study derived embryological from neural crest cells, 
versus adipose tissue throughout the body which is 
generally mesodermal in origin. The eyelid, therefore, 
provides a unique place to compare orbital stem cells 
(nasal fat pad) with fat more similar to systemic 
adipose tissue (central fat pads). Mesenchymal stem 
cells transplanted into the vitreous body in a rodent 
model of glaucoma showed considerable capacity to 
protect retinal ganglion cell degeneration. This did not 
require any differentiation or integration of the 
transplanted stem cells. Similar results including RGC 
neuro-protection have been demonstrated in models of 
retinal ischemia. As a cell replacement therapy for 
glaucoma; stem cells face a much tougher set of 
hurdles. Optimal cellular integration may be limited by 
immune reactivity, response to injury, or factors found 
in development but missing in the adult 
microenvironment. 
Stem cell replacement for ophthalmic of ganglion 
cells integrate with their presynaptic cells in the retina 
to receive visual information, and project their axons 
down the optic nerve and properly wire up with their 
targets in the lateral geniculate nucleus of the thalamus 
and other regions of the brain [29, 30]. 
Haptics and Robotics for Ophthalmic Surgery and 
Therapy 
Recently the effect of “Nano surgeries” in the 
vitreous, robots consist of the introduction of biological 
fluids as MEMS: Micro-electro-mechanical systems that 
do not require a replaceable total vitreous and are less 
invasive, and only require monitoring with another 
chamber. 
But at the same time new surgical instruments must 
be developed and patented to be appropriate for the 
insertion of these required micro and nano insertions. 
Researchers of Society of Photo-optical 
Instrumentation Engineers (SPIE) have presented an 
ophthalmic instrument for innovative analyses of the 
eye microcirculation. The developed system employs a 
laser source to perform the DWS (diffusing-wave-
spectroscopy) analysis of the light intensity back 
diffused by the ocular fundus structures, thus allowing 
a noninvasive detection of changes and modulations of 
both optical and dynamical properties of blood flow. 
The reported preliminary experimental results recorded 
in-vivo on rabbits' ocular fundus, demonstrate the 
ability of the system to detect nano-micro-aggregates 
carried by the blood flow in the ocular fundus. 
The Da Vinci Project, which incorporates robotic 
surgery, has already begun work on robotic surgery in 
ophthalmology. The California group Jules Stein Eye 
Institute at the University of California and the Center 
for Advanced Surgical and Interventional Technology, 
recently published advances in ophthalmic surgery. In 
Colombia, several institutions already exist with Da 
Vinci, so it would be interesting to train health 
professionals in these new technologies to improve the 
quality of life of patients. The U.S. Food and Drug 
Administration approved the Implantable Miniature 
Telescope (IMT), which works like the telephoto lens of 
a camera in 2010 [32, 33]. 
For less standardized procedures, such as 
vitreoretinal surgery, robotic augmentation could 
ultimately increase efficiency, amplify scale to allow 
performance of otherwise difficult tasks (e.g. sub retinal 
delivery of medication or stem cells), decrease 
complication rates by reducing tremor and increasing 
precision, and permit tele-surgical care in remote 
locations. Several obstacles remain before robotic 
surgery will become a clinical reality in ophthalmology. 
High cost, a steep learning curve, and patient trust all 
present individual challenges. The surgical procedure 
involves removing the eye's natural lens, as with 
cataract surgery, and replacing the lens with the IMT. 
DISCUSSION 
Eye health must turn our attention to new 
developments in order to take pause and review 
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classrooms to include physical theories in the teaching 
curricula, for example, physics memristors, nano-
devices, and augmented reality in order to wake up the 
future eye care professionals, and to give visual health 
research groups more transdisciplinary scenarios and 
less segmented. To describe the biological sciences as 
"nanos", create new languages such as the nano-
polymer for visual health as alternatives for patients 
with visual difficulties. As visual health researchers we 
should include in our search engine: augmented reality 
for the blind, visual tele-rehabilitation, diagnostic 
applications in molecular biology and visual 
applications, optical coherence tomography, nano-
polymers, among others, to be eyeopeners to 
multidisciplinary research projects in ophthalmology. 
How to incorporate this technology in our country? 
First with high-level academic training in doctorates, 
have the possibility to make strategic monitoring to see 
which devices are effective, or that is required in our 
environment according to the visual needs of the 
country and try to make innovations that will meet 
those needs. State investment is required, partnerships 
with universities and private companies to implement, 
build and test these findings, as we break the learning 
technology segmented gaps, isolated research and 
build partnerships among universities with high-tech 
experts in institutes in these countries. Although the 
items for transfer in science and technology have 
improved, alliances between transnational research 
groups should be a priority to bridge the gaps. 
Elsewhere on curriculum flexibility, to be able to include 
some internships between biomedical engineers, 
electronic engineers and to support programs of 
Faculties of eyecare with different elective disciplinary 
programs, to expand our horizons with electronics 
engineers or to allow a master's level training to share 
experiences, or encourage the development of 
collaborative working groups, is another way for 
research groups from the Universities to open doors to 
training and curricular flexibility to improve quality of life 
and safety of patients requiring eye treatments or 
diagnostic advantage of new technologies in the 
population. 
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